|
| Efferocytosis: Burying cell corpses to regulate tolerance and immunity |
|
https://doi.org/10.18632/oncotarget.4402
Maziar Divangahi
|
| 14721-14722 |
|
| Reversing stem cell aging |
|
https://doi.org/10.18632/oncotarget.4403
Jiyung Shin, Mary Mohrin, and Danica Chen
|
| 14723-14724 |
|
| Catalytically inactive telomerase in oncogenesis |
|
https://doi.org/10.18632/oncotarget.4404
Vinay Tergaonkar
|
| 14725-14726 |
|
| Ubiquitin regulates dissociation of DNA repair factors from chromatin |
|
https://doi.org/10.18632/oncotarget.4410
Petra Beli, and Stephen P. Jackson
|
| 14727-14728 |
|
| ATM in senescence |
|
https://doi.org/10.18632/oncotarget.4411
Katherine M. Aird, and Rugang Zhang
|
| 14729-14730 |
|
| PeptidesiRNA nanotherapeutics in arthritis |
|
https://doi.org/10.18632/oncotarget.4439
Christine T.N. Pham, Hua Pan, and Samuel A. Wickline
|
| 14731-14732 |
|
| Heme oxygenase1: for better for worse in sickness and in health |
|
https://doi.org/10.18632/oncotarget.4440
MarÃa Emilia Solano, and Petra Clara Arck
|
| 14733-14734 |
|
| Thyroid hormone and antiapoptosis in tumor cells |
|
https://doi.org/10.18632/oncotarget.4023
Hung-Yun Lin, Gennadi V. Glinsky, Shaker A. Mousa, and Paul J. Davis
|
| 14735-14743 |
|
| Genetic heterogeneity in cholangiocarcinoma: a major challenge for targeted therapies |
|
https://doi.org/10.18632/oncotarget.4539
Giovanni Brandi, Andrea Farioli, Annalisa Astolfi, Guido Biasco, and Simona Tavolari
|
| 14744-14753 |
|
| AMPactivated kinase AMPK regulates activity of HER2 and EGFR in breast cancer |
|
https://doi.org/10.18632/oncotarget.4474
Teraneh Z. Jhaveri, Juhyung Woo, Xiaobin Shang, Ben Ho Park, and Edward Gabrielson
|
| 14754-14765 |
|
| RNA nanoparticle as a vector for targeted siRNA delivery into glioblastoma mouse model |
|
https://doi.org/10.18632/oncotarget.3632
Tae Jin Lee, Farzin Haque, Dan Shu, Ji Young Yoo, Hui Li, Robert A. Yokel, Craig Horbinski, Tae Hyong Kim, Sung-Hak Kim, Chang-Hyuk Kwon, Ichiro Nakano, Balveen Kaur, Peixuan Guo, and Carlo M. Croce
|
| 14766-14776 |
|
| Mitochondrial biogenesis is required for the anchorageindependent survival and propagation of stemlike cancer cells |
|
https://doi.org/10.18632/oncotarget.4401
Arianna De Luca, Marco Fiorillo, Maria Peiris-Pagès, Bela Ozsvari, Duncan L. Smith, Rosa Sanchez-Alvarez, Ubaldo E. Martinez-Outschoorn, Anna Rita Cappello, Vincenzo Pezzi, Michael P. Lisanti, and Federica Sotgia
|
| 14777-14795 |
|
| Inhibition of COP9signalosome CSN deneddylating activity and tumor growth of diffuse large Bcell lymphomas by doxycycline |
|
https://doi.org/10.18632/oncotarget.4193
Mary Pulvino, Luojing Chen, David Oleksyn, Jing Li, George Compitello, Randy Rossi, Stephen Spence, Vijaya Balakrishnan, Craig Jordan, Brian Poligone, Carla Casulo, Richard Burack, Joel L. Shapiro, Steven Bernstein, Jonathan W. Friedberg, Raymond J. Deshaies, Hartmut Land, and Jiyong Zhao
|
| 14796-14813 |
|
| KLF4SQSTM1/p62associated prosurvival autophagy contributes to carfilzomib resistance in multiple myeloma models |
|
https://doi.org/10.18632/oncotarget.4530
Irene Riz, Teresa S. Hawley, and Robert G. Hawley
|
| 14814-14831 |
|
| The oncometabolite D2hydroxyglutarate induced by mutant IDH1 or 2 blocks osteoblast differentiation in vitro and in vivo |
|
https://doi.org/10.18632/oncotarget.4024
Johnny Suijker, Hans J. Baelde, Helene Roelofs, Anne-Marie Cleton-Jansen, and Judith V.M.G. Bovée
|
| 14832-14842 |
|
| VGF expression by T lymphocytes in patients with Alzheimer’s disease |
|
https://doi.org/10.18632/oncotarget.3569
Stefan Busse, Johann Steiner, Sarah Glorius, Henrik Dobrowolny, Sabrina Greiner-Bohl, Christian Mawrin, Ursula Bommhardt, Roland Hartig, Bernhard Bogerts, and Mandy Busse
|
| 14843-14851 |
|
| Genomic instability and cellular stress in organ biopsies and peripheral blood lymphocytes from patients with colorectal cancer and predisposing pathologies |
|
https://doi.org/10.18632/oncotarget.4032
Sara Lombardi, Ilenia Fuoco, Giorgia di Fluri, Francesco Costa, Angelo Ricchiuti, Graziano Biondi, Vincenzo Nardini, and Roberto Scarpato
|
| 14852-14864 |
|
| Prevalence and predictive factors of osteoporosis in systemic sclerosis patients: a casecontrol study |
|
https://doi.org/10.18632/oncotarget.3806
Mathilde Marot, Antoine Valéry, Eric Esteve, Guido Bens, Adelheid Müller, Stéphanie Rist, Hechmi Toumi, and Eric Lespessailles
|
| 14865-14873 |
|
| Zinc finger factor 521 enhances adipogenic differentiation of mouse multipotent cells and human bone marrow mesenchymal stem cells |
|
https://doi.org/10.18632/oncotarget.3900
Kuo-Yun Tseng, and Shankung Lin
|
| 14874-14884 |
|
| Mitochondrial fission determines cisplatin sensitivity in tongue squamous cell carcinoma through the BRCA1–miR5935p–MFF axis |
|
https://doi.org/10.18632/oncotarget.3659
Song Fan, Bodu Liu, Lijuan Sun, Xiao-bin Lv, Zhaoyu Lin, Weixiong Chen, Weiliang Chen, Qionglan Tang, Youyuan Wang, Yuxiong Su, Shaowen Jin, Daming Zhang, Jianglong Zhong, Yilin Li, Bin Wen, Zhang Zhang, Pu Yang, Bin Zhou, Qixiang Liang, Xing Yu, Yinghua Zhu, Pengnan Hu, Junjun Chu, Wei Huang, Yuhuan Feng, Hongzhuang Peng, Qihong Huang, Erwei Song, and Jinsong Li
|
| 14885-14904 |
|
| Human bone marrow niche chemoprotection mediated by cytochrome P450 enzymes |
|
https://doi.org/10.18632/oncotarget.3614
Salvador Alonso, Meng Su, Jace W. Jones, Sudipto Ganguly, Maureen A. Kane, Richard J. Jones, and Gabriel Ghiaur
|
| 14905-14912 |
|
| Overexpression of PP2A inhibitor SET oncoprotein is associated with tumor progression and poor prognosis in human nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.3818
Hao Liu, Yixue Gu, Hongsheng Wang, Jiang Yin, Guopei Zheng, Zhijie Zhang, Minyin Lu, Chenkun Wang, and Zhimin He
|
| 14913-14925 |
|
| Cyclindependent kinase inhibitor dinaciclib potently synergizes with cisplatin in preclinical models of ovarian cancer |
|
https://doi.org/10.18632/oncotarget.3717
Xiu-Xiu Chen, Feng-Feng Xie, Xiu-Jie Zhu, Feng Lin, Shi-Shi Pan, Li-Hua Gong, Jian-Ge Qiu, Wen-Ji Zhang, Qi-Wei Jiang, Xiao-Long Mei, You-Qiu Xue, Wu-Ming Qin, Zhi Shi, and Xiao-Jian Yan
|
| 14926-14939 |
|
| Foretinib inhibits angiogenesis lymphangiogenesis and tumor growth of pancreatic cancer in vivo by decreasing VEGFR2/3 and TIE2 signaling |
|
https://doi.org/10.18632/oncotarget.3613
Hsiu-Mei Chen, Chia-Hua Tsai, and Wen-Chun Hung
|
| 14940-14952 |
|
| Targeting Notch1 and proteasome as an effective strategy to suppress Tcell lymphoproliferative neoplasms |
|
https://doi.org/10.18632/oncotarget.3621
Lujun Yang, Shuangfeng Zhang, Suraj Konnath George, Rong Teng, Xuefen You, Mengqi Xu, Hong Liu, Xiaoping Sun, Hesham M. Amin, and Wenyu Shi
|
| 14953-14969 |
|
| Essential role for cyclicAMP responsive element binding protein 1 CREB in the survival of acute lymphoblastic leukemia |
|
https://doi.org/10.18632/oncotarget.3911
Naomi E. van der Sligte, Kim R. Kampen, Arja ter Elst, Frank J.G. Scherpen, Tiny G.J. Meeuwsen-de Boer, Victor Guryev, Frank N. van Leeuwen, Steven M. Kornblau, and Eveline S.J.M. de Bont
|
| 14970-14981 |
|
| RRAD inhibits the Warburg effect through negative regulation of the NFκB signaling |
|
https://doi.org/10.18632/oncotarget.3719
Juan Liu, Cen Zhang, Rui Wu, Meihua Lin, Yingjian Liang, Jia Liu, Xiaolong Wang, Bo Yang, and Zhaohui Feng
|
| 14982-14992 |
|
| MicroRNA451 regulates stemness of side population cells via PI3K/Akt/mTOR signaling pathway in multiple myeloma |
|
https://doi.org/10.18632/oncotarget.3802
Juan Du, Shuyan Liu, Jie He, Xi Liu, Ying Qu, Wenqing Yan, Jianling Fan, Rong Li, Hao Xi, Weijun Fu, Chunyang Zhang, Jing Yang, and Jian Hou
|
| 14993-15007 |
|
| PARP inhibitor ABT888 affects response of MDAMB231 cells to doxorubicin treatment targeting Snail expression |
|
https://doi.org/10.18632/oncotarget.3634
Germano Mariano, Maria Rosaria Ricciardi, Daniela Trisciuoglio, Michele Zampieri, Fabio Ciccarone, Tiziana Guastafierro, Roberta Calabrese, Elisabetta Valentini, Agostino Tafuri, Donatella Del Bufalo, Paola Caiafa, and Anna Reale
|
| 15008-15021 |
|
| Fibulin5 inhibits Wnt/βcatenin signaling in lung cancer |
|
https://doi.org/10.18632/oncotarget.3609
Xiaojun Chen, Xiaomeng Song, Wen Yue, Dongshi Chen, Jian Yu, Zhi Yao, and Lin Zhang
|
| 15022-15034 |
|
| MicroRNA21 plays an oncogenic role by targeting FOXO1 and activating the PI3K/AKT pathway in diffuse large Bcell lymphoma |
|
https://doi.org/10.18632/oncotarget.3729
Heounjeong Go, Ji-Young Jang, Pil-Jong Kim, Young-Goo Kim, Soo Jeong Nam, Jin Ho Paik, Tae Min Kim, Dae Seog Heo, Chul-Woo Kim, and Yoon Kyung Jeon
|
| 15035-15049 |
|
| Thyroid hormonemediated regulation of lipocalin 2 through the Met/FAK pathway in liver cancer |
|
https://doi.org/10.18632/oncotarget.3670
I-Hsiao Chung, Cheng-Yi Chen, Yang-Hsiang Lin, Hsiang-Cheng Chi, Pei-ju Tai, Chia-Jung Liao, Chung-Ying Tsai, Syuan-Ling Lin, Meng-Han Wu, Ching-Ying Chen, and Kwang-Huei Lin
|
| 15050-15064 |
|
| HER2 and HER3 expression in liver metastases of patients with colorectal cancer |
|
https://doi.org/10.18632/oncotarget.3527
Hanna Styczen, Iris Nagelmeier, Tim Beissbarth, Manuel Nietert, Kia Homayounfar, Thilo Sprenger, Ute Boczek, Kathrin Stanek, Julia Kitz, Hendrik A. Wolff, Michael B. Ghadimi, Peter Middel, Torsten Liersch, Josef Rüschoff, and Lena-Christin Conradi
|
| 15065-15076 |
|
| Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis |
|
https://doi.org/10.18632/oncotarget.3730
Xi Feng, Frank Szulzewsky, Alexan Yerevanian, Zhihong Chen, David Heinzmann, Rikke Darling Rasmussen, Virginia Alvarez-Garcia, Yeonghwan Kim, Bingcheng Wang, Ilaria Tamagno, Hao Zhou, Xiaoxia Li, Helmut Kettenmann, Richard M. Ransohoff, and Dolores Hambardzumyan
|
| 15077-15094 |
|
| Upregulation of spondin2 predicts poor survival of colorectal carcinoma patients |
|
https://doi.org/10.18632/oncotarget.3822
Qian Zhang, Xiao-Qing Wang, Jie Wang, Shu-Jian Cui, Xiao-Min Lou, Bing Yan, Jie Qiao, Ying-Hua Jiang, Li-Jun Zhang, Peng-Yuan Yang, and Feng Liu
|
| 15095-15110 |
|
| Smallmolecule induction of phosphoeIF4E sumoylation and degradation via targeting its phosphorylated serine 209 residue |
|
https://doi.org/10.18632/oncotarget.3615
Ying Gu, Hong Zhou, Yichao Gan, Jiawei Zhang, Jianghua Chen, Xiaoxian Gan, Hongzhi Li, Weiwei Zheng, Zhipeng Meng, Xiaoxiao Ma, Xichun Wang, Xiaohua Xu, Ganyu Xu, Xiaoya Lu, Yun Liang, Xuzhao Zhang, Xinliang Lu, Wendong Huang, and Rongzhen Xu
|
| 15111-15121 |
|
| Irreversible dual inhibitory mode: the novel Btk inhibitor PLS123 demonstrates promising antitumor activity in human Bcell lymphoma |
|
https://doi.org/10.18632/oncotarget.3824
Ning Ding, Xitao Li, Yunfei Shi, Lingyan Ping, Lina Wu, Kai Fu, Lixia Feng, Xiaohui Zheng, Yuqin Song, Zhengying Pan, and Jun Zhu
|
| 15122-15136 |
|
| Silencing of PMEPA1 accelerates the growth of prostate cancer cells through AR NEDD4 and PTEN |
|
https://doi.org/10.18632/oncotarget.3526
Hua Li, Ahmed A. Mohamed, Shashwat Sharad, Elizabeth Umeda, Yingjie Song, Denise Young, Gyorgy Petrovics, David G. McLeod, Isabell A. Sesterhenn, Taduru Sreenath, Albert Dobi, and Shiv Srivastava
|
| 15137-15149 |
|
| Insulinlike growth factor binding protein3 inhibits cell adhesion via suppression of integrin β4 expression |
|
https://doi.org/10.18632/oncotarget.3825
Hyo-Jong Lee, Ji-Sun Lee, Su Jung Hwang, and Ho-Young Lee
|
| 15150-15163 |
|
| MMP3mediated tumor progression is controlled transcriptionally by a novel IRF8MMP3 interaction |
|
https://doi.org/10.18632/oncotarget.3897
Debarati Banik, Colleen S. Netherby, Paul N. Bogner, and Scott I. Abrams
|
| 15164-15179 |
|
| Upregulation of miR572 transcriptionally suppresses SOCS1 and p21 and contributes to human ovarian cancer progression |
|
https://doi.org/10.18632/oncotarget.3737
Xin Zhang, Junling Liu, Dan Zang, Shu Wu, Aibin Liu, Jinrong Zhu, Geyan Wu, Jun Li, and Lili Jiang
|
| 15180-15193 |
|
| Elevated MARCKS phosphorylation contributes to unresponsiveness of breast cancer to paclitaxel treatment |
|
https://doi.org/10.18632/oncotarget.3827
Ching-Hsien Chen, Chun-Ting Cheng, Yuan Yuan, Jing Zhai, Muhammad Arif, Lon Wolf R. Fong, Reen Wu, and David K. Ann
|
| 15194-15208 |
|
| Accelerated hepatocellular carcinoma development in CUL4B transgenic mice |
|
https://doi.org/10.18632/oncotarget.3829
Jupeng Yuan, Baichun Jiang, Aizhen Zhang, Yanyan Qian, Haining Tan, Jiangang Gao, Changshun Shao, and Yaoqin Gong
|
| 15209-15221 |
|
| MiR3383p inhibits epithelialmesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signaling |
|
https://doi.org/10.18632/oncotarget.3835
Na Huang, Zhenzhen Wu, Li Lin, Minyu Zhou, Lin Wang, Huanrong Ma, Jianling Xia, Jianping Bin, Yulin Liao, and Wangjun Liao
|
| 15222-15234 |
|
| Malignant T cells express lymphotoxin α and drive endothelial activation in cutaneous T cell lymphoma |
|
https://doi.org/10.18632/oncotarget.3837
Britt Lauenborg, Louise Christensen, Ulrik Ralfkiaer, Katharina L. Kopp, Lars Jønson, Sally Dabelsteen, Charlotte M. Bonefeld, Carsten Geisler, Lise Mette R. Gjerdrum, Qian Zhang, Mariusz A. Wasik, Elisabeth Ralfkiaer, Niels Ødum, and Anders Woetmann
|
| 15235-15249 |
|
| The cJun/RHOB/AKT pathway confers resistance of BRAFmutant melanoma cells to MAPK inhibitors |
|
https://doi.org/10.18632/oncotarget.3888
Audrey Delmas, Julia Cherier, Magdalena Pohorecka, Claire Medale-Giamarchi, Nicolas Meyer, Anne Casanova, Olivier Sordet, Laurence Lamant, Ariel Savina, Anne Pradines, and Gilles Favre
|
| 15250-15264 |
|
| Consequences of combining siRNAmediated DNA methyltransferase 1 depletion with 5aza2’deoxycytidine in human leukemic KG1 cells |
|
https://doi.org/10.18632/oncotarget.3317
Stéphane Vispé, Arthur Deroide, Emeline Davoine, Cécile Desjobert, Fabrice Lestienne, Lucie Fournier, Natacha Novosad, Sophie Bréand, Jérôme Besse, Florence Busato, Jörg Tost, Luc De Vries, Didier Cussac, Joëlle Riond, and Paola B. Arimondo
|
| 15265-15282 |
|
| Selective killing of breast cancer cells expressing activated CD44 using CD44 ligandcoated nanoparticles in vitro and in vivo |
|
https://doi.org/10.18632/oncotarget.3681
Cuixia Yang, Yiqing He, Huizhen Zhang, Yiwen Liu, Wenjuan Wang, Yan Du, and Feng Gao
|
| 15283-15296 |
|
| A small molecule inhibitor of atypical protein kinase C signaling inhibits pancreatic cancer cell transformed growth and invasion |
|
https://doi.org/10.18632/oncotarget.3812
Amanda M. Butler, Michele L. Scotti Buzhardt, Eda Erdogan, Shuhua Li, Kristin S. Inman, Alan P. Fields, and Nicole R. Murray
|
| 15297-15310 |
|
| Tag SNPs in long noncoding RNA H19 contribute to susceptibility to gastric cancer in the Chinese Han population |
|
https://doi.org/10.18632/oncotarget.3840
Chao Yang, Ran Tang, Xiang Ma, Younan Wang, Dakui Luo, Zekuan Xu, Yi Zhu, and Li Yang
|
| 15311-15320 |
|
| Axl receptor tyrosine kinase is upregulated in metformin resistant prostate cancer cells |
|
https://doi.org/10.18632/oncotarget.4148
Nitu Bansal, Prasun J. Mishra, Mark Stein, Robert S. DiPaola, and Joseph R. Bertino
|
| 15321-15331 |
|
| Inhibition of insulinlike growth factor receptor/AKT/mammalian target of rapamycin axis targets colorectal cancer stem cells by attenuating mevalonateisoprenoid pathway in vitro and in vivo |
|
https://doi.org/10.18632/oncotarget.3684
Chetna Sharon, Somesh Baranwal, Nirmita J. Patel, Daniel Rodriguez-Agudo, William M. Pandak, Adhip P. N. Majumdar, Geoffrey Krystal, and Bhaumik B. Patel
|
| 15332-15347 |
|
| Lycorine is a novel inhibitor of the growth and metastasis of hormonerefractory prostate cancer |
|
https://doi.org/10.18632/oncotarget.3610
Meichun Hu, Shihong Peng, Yundong He, Min Qin, Xiaonan Cong, Yajing Xing, Mingyao Liu, and Zhengfang Yi
|
| 15348-15361 |
|
| The intrinsic stiffness of human trabecular meshwork cells increases with senescence |
|
https://doi.org/10.18632/oncotarget.3798
Joshua T. Morgan, Vijay Krishna Raghunathan, Yow-Ren Chang, Christopher J. Murphy, and Paul Russell
|
| 15362-15374 |
|
| Proteogenomic analysis reveals exosomes are more oncogenic than ectosomes |
|
https://doi.org/10.18632/oncotarget.3801
Shivakumar Keerthikumar, Lahiru Gangoda, Michael Liem, Pamali Fonseka, Ishara Atukorala, Cemil Ozcitti, Adam Mechler, Christopher G. Adda, Ching-Seng Ang, and Suresh Mathivanan
|
| 15375-15396 |
|
| TR4 nuclear receptor increases prostate cancer invasion via decreasing the miR3733p expression to alter TGFβR2/pSmad3 signals |
|
https://doi.org/10.18632/oncotarget.3778
Xiaofu Qiu, Jin Zhu, Yin Sun, Kun Fan, Dong-Rong Yang, Gonghui Li, Guosheng Yang, and Chawnshang Chang
|
| 15397-15409 |
|
| Inhibition of thioredoxin 1 leads to apoptosis in drugresistant multiple myeloma |
|
https://doi.org/10.18632/oncotarget.3795
Prahlad V. Raninga, Giovanna Di Trapani, Slavica Vuckovic, Maneet Bhatia, and Kathryn F. Tonissen
|
| 15410-15424 |
|
| Sensitivity to cdk1inhibition is modulated by p53 status in preclinical models of embryonal tumors |
|
https://doi.org/10.18632/oncotarget.3908
Melanie Schwermer, Sangkyun Lee, Johannes Köster, Tom van Maerken, Harald Stephan, Angelika Eggert, Katharina Morik, Johannes H. Schulte, and Alexander Schramm
|
| 15425-15435 |
|
| OVOL guides the epithelialhybridmesenchymal transition |
|
https://doi.org/10.18632/oncotarget.3623
Dongya Jia, Mohit Kumar Jolly, Marcelo Boareto, Princy Parsana, Steven M. Mooney, Kenneth J. Pienta, Herbert Levine, and Eshel Ben-Jacob
|
| 15436-15448 |
|
| DNA strand breaks induced by nuclear hijacking of neuronal NOS as an anticancer effect of 2methoxyestradiol |
|
https://doi.org/10.18632/oncotarget.3913
Magdalena Gorska, Alicja Kuban-Jankowska, Michal Zmijewski, Antonella Marino Gammazza, Francesco Cappello, Maciej Wnuk, Monika Gorzynik, Iwona Rzeszutek, Agnieszka Daca, Anna Lewinska, and Michal Wozniak
|
| 15449-15463 |
|
| Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients’ cells |
|
https://doi.org/10.18632/oncotarget.3895
Elena Ciaglia, Giovanni Torelli, Simona Pisanti, Paola Picardi, Alba D’Alessandro, Chiara Laezza, Anna Maria Malfitano, Donatella Fiore, Antonio Christian Pagano Zottola, Maria Chiara Proto, Giuseppe Catapano, Patrizia Gazzerro, and Maurizio Bifulco
|
| 15464-15481 |
|
| AntiCSF1 treatment is effective to prevent carcinoma invasion induced by monocytederived cells but scarcely by microglia |
|
https://doi.org/10.18632/oncotarget.3855
Eva Rietkötter, Annalen Bleckmann, Michaela Bayerlová, Kerstin Menck, Han-Ning Chuang, Britta Wenske, Hila Schwartz, Neta Erez, Claudia Binder, Uwe-Karsten Hanisch, and Tobias Pukrop
|
| 15482-15493 |
|
| Trametinib modulates cancer multidrug resistance by targeting ABCB1 transporter |
|
https://doi.org/10.18632/oncotarget.3820
Jian-Ge Qiu, Yao-Jun Zhang, Yong Li, Jin-Ming Zhao, Wen-Ji Zhang, Qi-Wei Jiang, Xiao-Long Mei, You-Qiu Xue, Wu-Ming Qin, Yang Yang, Di-Wei Zheng, Yao Chen, Meng-Ning Wei, and Zhi Shi
|
| 15494-15509 |
|
| MYCN amplification confers enhanced folate dependence and methotrexate sensitivity in neuroblastoma |
|
https://doi.org/10.18632/oncotarget.3732
Diana T. Lau, Claudia L. Flemming, Samuele Gherardi, Giovanni Perini, André Oberthuer, Matthias Fischer, Dilafruz Juraeva, Benedikt Brors, Chengyuan Xue, Murray D. Norris, Glenn M. Marshall, Michelle Haber, Jamie I. Fletcher, and Lesley J. Ashton
|
| 15510-15523 |
|
| Targeting pancreatitis blocks tumorinitiating stem cells and pancreatic cancer progression |
|
https://doi.org/10.18632/oncotarget.3499
Altaf Mohammed, Naveena B. Janakiram, Venkateshwar Madka, Misty Brewer, Rebekah L. Ritchie, Stan Lightfoot, Gaurav Kumar, Michael Sadeghi, Jagan Mohan R. Patlolla, Hiroshi Y. Yamada, Zobeida Cruz-Monserrate, Randal May, Courtney W. Houchen, Vernon E. Steele, and Chinthalapally V. Rao
|
| 15524-15539 |
|
| Anchoring of both PKARIIα and 1433θ regulates retinoic acid induced 16 mediated phosphorylation of heat shock protein 70 |
|
https://doi.org/10.18632/oncotarget.3702
Cui-Ling Ding, Gang Xu, Hai-Lin Tang, Shi-Ying Zhu, Lan-Juan Zhao, Hao Ren, Ping Zhao, Zhong-Tian Qi, and Wen Wang
|
| 15540-15550 |
|
| Exploiting the potential of autophagy in cisplatin therapy: A new strategy to overcome resistance |
|
https://doi.org/10.18632/oncotarget.3902
Jesús GarcÃa-Cano, Gorbatchev Ambroise, Raquel Pascual-Serra, M Carmen Carrión, Leticia Serrano-Oviedo, Marta Ortega-Muelas, Francisco J. Cimas, Sebastià Sabater, MarÃa José Ruiz-Hidalgo, Isabel Sanchez Perez, Antonio Mas, Félix A. Jalón, Aimé Vazquez, and Ricardo Sánchez-Prieto
|
| 15551-15565 |
|
| Gap junctions modulate glioma invasion by direct transfer of microRNA |
|
https://doi.org/10.18632/oncotarget.3904
Xiaoting Hong, Wun Chey Sin, Andrew L. Harris, and Christian C. Naus
|
| 15566-15577 |
|
| Shortterm expansion of breast circulating cancer cells predicts response to anticancer therapy |
|
https://doi.org/10.18632/oncotarget.3903
Bee Luan Khoo, Soo Chin Lee, Prashant Kumar, Tuan Zea Tan, Majid Ebrahimi Warkiani, Samuel GW Ow, Sayantani Nandi, Chwee Teck Lim, and Jean Paul Thiery
|
| 15578-15593 |
|
| PBK/TOPK enhances aggressive phenotype in prostate cancer via βcateninTCF/LEFmediated matrix metalloproteinases production and invasion |
|
https://doi.org/10.18632/oncotarget.3709
Joshua D. Brown-Clay, Deepika N. Shenoy, Olga Timofeeva, Bhaskar V. Kallakury, Asit K. Nandi, and Partha P. Banerjee
|
| 15594-15609 |
|
| Enolase1 is a therapeutic target in endometrial carcinoma |
|
https://doi.org/10.18632/oncotarget.3639
Mengyang Zhao, Weiyi Fang, Yan Wang, Suiqun Guo, Luyun Shu, Lijing Wang, YiYu Chen, Qiaofen Fu, Yan Liu, Shengni Hua, Yue Fan, Yiyi Liu, Xiaojie Deng, Rongcheng Luo, Zhong Mei, Qinping Jiang, and Zhen Liu
|
| 15610-15627 |
|
| Ccdc6 knockin mice develop thyroid hyperplasia associated to an enhanced CREB1 activity |
|
https://doi.org/10.18632/oncotarget.3858
Vincenza Leone, Concetta Langella, Francesco Esposito, Claudio Arra, Giuseppe Palma, Domenica Rea, Orlando Paciello, Francesco Merolla, Davide De Biase, Serenella Papparella, Angela Celetti, and Alfredo Fusco
|
| 15628-15638 |
|
| Comprehensive characterization of chemotherapeutic efficacy on metastases in the established gastric neuroendocrine cancer patient derived xenograft model |
|
https://doi.org/10.18632/oncotarget.3712
Jiahua Jiang, Daisy Dandan Wang, Mengmeng Yang, Dawei Chen, Liang Pang, Sheng Guo, Jie Cai, Jean-Pierre Wery, Linda Li, Henry Qixiang Li, and Peter Ping Lin
|
| 15639-15651 |
|
| Metformininduced energy deficiency leads to the inhibition of lipogenesis in prostate cancer cells |
|
https://doi.org/10.18632/oncotarget.3404
Camille Loubière, Thomas Goiran, Kathiane Laurent, Zied Djabari, Jean-François Tanti, and Frédéric Bost
|
| 15652-15661 |
|
| Prognostic value of a 92probe signature in breast cancer |
|
https://doi.org/10.18632/oncotarget.3525
Salima Akter, Tae Gyu Choi, Minh Nam Nguyen, Abel Matondo, Jin-Hwan Kim, Yong Hwa Jo, Ara Jo, Muhammad Shahid, Dae Young Jun, Ji Youn Yoo, Yen Ngoc Nguyen Ngo, Seong-Wook Seo, Liaquat Ali, Ju-Seog Lee, Kyung-Sik Yoon, Wonchae Choe, Insug Kang, Joohun Ha, Jayoung Kim, and Sung Soo Kim
|
| 15662-15680 |
|
| RAS testing in metastatic colorectal cancer: excellent reproducibility amongst 17 Dutch pathology centers |
|
https://doi.org/10.18632/oncotarget.3804
Annemarie Boleij, Bastiaan B.J. Tops, Paul D.M. Rombout, Elizabeth M. Dequeker, Marjolijn J.L. Ligtenberg, J. Han van Krieken, and Dutch RAS EQA Initiative
|
| 15681-15689 |
|
| Clinical evaluation of stereotactic radiation therapy for recurrent or second primary mediastinal lymph node metastases originating from nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.3704
Mao-Bin Meng, Huan-Huan Wang, Nicholas G. Zaorsky, Xian-Zhi Zhao, Zhi-Qiang Wu, Bo Jiang, Yong-Chun Song, Hong-Qing Zhuang, Feng-Tong Li, Lu-Jun Zhao, Chang-Li Wang, Kai Li, Ping Wang, and Zhi-Yong Yuan
|
| 15690-15703 |
